BRPI0510075A - benzoxazocines and their therapeutic use as monoamine resorption inhibitors - Google Patents
benzoxazocines and their therapeutic use as monoamine resorption inhibitorsInfo
- Publication number
- BRPI0510075A BRPI0510075A BRPI0510075-5A BRPI0510075A BRPI0510075A BR PI0510075 A BRPI0510075 A BR PI0510075A BR PI0510075 A BRPI0510075 A BR PI0510075A BR PI0510075 A BRPI0510075 A BR PI0510075A
- Authority
- BR
- Brazil
- Prior art keywords
- optionally substituted
- alkyl
- unsubstituted
- cycloalkyl
- alkenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
BENZOXAZOCINAS E SEU USO TERAPêUTICO COMO INIBIDORES DE REABSORçãO DE MONOAMINA Compostos tendo utilidade terapêutica são da fórmula geral (1) onde R~ 1~ é H, alquila C~ 1~-C~ 6~ opcionalmente substituída por F ou cicloalquila C~ 3~- C~ 6~ ou alquenila C~ 2~-C~ 4~; A é O, CH~ 2~ ou S (O)~ n~ onde n é 0-2; Um entre W, X, Y e Z é N, CH ou CR~ 3~ e os outros são CH; R~ 2~ é heteroarila C~ 5~-C~ 6~, Cicloalquila C~ 5~-C~ 10~ ou cicloalquenila opcionalmente contendo um ou mais heteroátomos selecionados entre O, N e S(O)~ n~ onde n é 0-2, e opcionalmente substituido por R~ 3~; ou um grupo fenila opcionalmente substituído em uma ou mais posições com um ou mais substituintes independentemente selecionados entre halogênio, CN, CF~ 3~, alquila C~ 1~-C~ 6~ e OR~ 1~, ou o grupo fenila é fundido com um anel de cinco ou seis membros que pode ser carbocíclico, heterocíclico (contendo 1-2 heteroátomos selecionados entre O, N e S), aromático ou heteroaromático (contendo 1-2 heteroátomos selecionados de O e N); R~ 3~ é selecionado dentre halogênio; CF~ 3~; CN; OR~ 5~; SO~ 2~N (R~ 5~)~ 2~; COR~ 5~; CO~ 2~R~ 5~; CON(R~ 5~)~ 2~; NR~ 1~COR~ 4~; NR~ 1~SO~ 2~R~ 4~; NR~ 1CO~ 2~R~ 4~; NR~ 1~CON(R~ 5~)~ 2~; alquila OC~ 1~-C~ 6~ substituída com R~ 3~; alquila C~ 1~-C~ 6~ opcionalmente substituída com R~ 3~ não substituído; cicloalquila C~ 3~-C~ 5~ opcionalmente substituída com R~ 3~ não substituído; alquenila C~ 2~-C~ 6~ opcionalmente substituído com R~ 3~ não substituído; alquinila C~ 2~-C~ 6~ opcionalmente substituído com R~ 3~ não substituído; arila opcionalmente substituída com R~ 3~ não substituído; e heterociclos aromáticos com cinco ou seis membros contendo 1-4 heteroátomos selecionados entre N e O; R~ 4~ é alquila C~ 1~-C~ 6~, alquenila C~ 2~-C~ 6~, alquinila C~ 2~-C~ 6~, cicloalquila C~ 3~-C~ 6~, arila e heteroarila; e R~ 5~ é H, alquila C~ 1~-C~ 6~, alquenila C~ 2~-C~ 6~, alquinila C~ 2~-C~ 6~, cicloalquila C~ 3~-C~ 6~, arila ou heteroarila e é igual ou diferente de outro R~ 5~; ou um sal farmacêuticamente aceitável do mesmo.BENZOXAZOCINS AND THEIR THERAPEUTIC USE AS MONOAMINE REHABORATION INHIBITORS Compounds having therapeutic utility are of the general formula (1) where R 1 is H, C 1 -C 6 alkyl optionally substituted by F or C 3 cycloalkyl -C6- or C2-6 alkenyl; A is O, CH ~ 2 ~ or S (O) ~ n ~ where n is 0-2; One of W, X, Y and Z is N, CH or CR 3 and the others are CH; R 2 is C 5 -C 6 heteroaryl, C 5 -C 10 cycloalkyl or cycloalkenyl optionally containing one or more heteroatoms selected from O, N and S (O) ~ n ~ where n is 0-2, and optionally substituted by R3-; or a phenyl group optionally substituted at one or more positions with one or more substituents independently selected from halogen, CN, CF-3 ~, C1-C6-alkyl and OR-1 ~, or the phenyl group is fused with a five or six membered ring which may be carbocyclic, heterocyclic (containing 1-2 heteroatoms selected from O, N and S), aromatic or heteroaromatic (containing 1-2 heteroatoms selected from O and N); R3 is selected from halogen; CF ~ 3 ~; CN; OR ~ 5 ~; SO ~ 2 ~ N (R ~ 5 ~) ~ 2 ~; COR ~ 5 ~; CO ~ 2 ~ R ~ 5 ~; CON (R 5 ~) ~ 2 ~; NR ~ 1 ~ COR ~ 4 ~; NR ~ 1 ~ SO ~ 2 ~ R ~ 4 ~; NR ~ 1CO ~ 2 ~ R ~ 4 ~; NR ~ 1 ~ CON (R ~ 5 ~) ~ 2 ~; C1-6 alkyl substituted with R3; C1 -C6 alkyl optionally substituted with unsubstituted R3; C3 -C5 cycloalkyl optionally substituted with unsubstituted R3; C 2 -C 6 alkenyl optionally substituted with unsubstituted R 3; C 2 -C 6 alkynyl optionally substituted with unsubstituted R 3; optionally substituted aryl with unsubstituted R3; and five- or six-membered aromatic heterocycles containing 1-4 heteroatoms selected from N and O; R4 is C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-6 cycloalkyl, aryl and heteroaryl; and R5 is H, C1 -C6 alkyl, C2 -C6 alkenyl, C2 -C6 alkynyl, C3 -C6 cycloalkyl aryl or heteroaryl and is the same or different from another R 5; or a pharmaceutically acceptable salt thereof.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0408863A GB0408863D0 (en) | 2004-04-21 | 2004-04-21 | Novel benzoxazocines |
GB0408862A GB0408862D0 (en) | 2004-04-21 | 2004-04-21 | Novel benzoxazocines |
PCT/GB2005/001519 WO2005103019A1 (en) | 2004-04-21 | 2005-04-21 | Benzoxazocines and their therapeutic use as monoamine reuptake inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0510075A true BRPI0510075A (en) | 2007-10-16 |
Family
ID=34965745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0510075-5A BRPI0510075A (en) | 2004-04-21 | 2005-04-21 | benzoxazocines and their therapeutic use as monoamine resorption inhibitors |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1740558A1 (en) |
JP (1) | JP2007533718A (en) |
AU (1) | AU2005235786A1 (en) |
BR (1) | BRPI0510075A (en) |
CA (1) | CA2558741A1 (en) |
IL (1) | IL177750A0 (en) |
NO (1) | NO20065057L (en) |
WO (1) | WO2005103019A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0504960D0 (en) * | 2005-03-10 | 2005-04-20 | Arakis Ltd | Benzoxazocines |
GB0506835D0 (en) * | 2005-04-04 | 2005-05-11 | Arakis Ltd | Therapeutic use of nefopam |
BR112012014471A2 (en) | 2009-12-15 | 2017-06-06 | Hospital For Sick Children | Method for treating scars and beta-catenin-mediated disorders using nefopam compounds |
ES2603032T3 (en) | 2010-07-15 | 2017-02-23 | Bayer Intellectual Property Gmbh | 3-Pyridyl-heteroarylcarboxamide compounds as pesticides |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3830803A (en) * | 1965-05-10 | 1974-08-20 | Riker Laboratories Inc | 5-loweralkyl-1-phenyl-1,3,4,6-tetrahydro-5h-benz(f)-2,5-oxazocines and 4-ones |
US3978085A (en) * | 1975-03-07 | 1976-08-31 | Riker Laboratories, Inc. | Process for benz[f]-2,5-oxazocines |
JPS5913770A (en) * | 1982-07-13 | 1984-01-24 | Sanwa Kagaku Kenkyusho:Kk | Novel 1-phenyl-2,5-benzothiazocine derivative and its preparation |
JPS5913760A (en) * | 1982-07-13 | 1984-01-24 | Sanwa Kagaku Kenkyusho:Kk | Novel benzazocine derivative and its preparation |
JP4907818B2 (en) * | 1999-11-03 | 2012-04-04 | エーエムアール テクノロジー インコーポレイテッド | Aryl and heteroaryl substituted tetrahydroisoquinolines and their use to prevent reuptake of norepinephrine, dopamine and serotonin |
EP1572672B1 (en) * | 2002-12-20 | 2008-08-13 | Sosei R&D Ltd. | Benzoxazocines and their use as monoamine-reuptake inhibitors |
-
2005
- 2005-04-21 CA CA002558741A patent/CA2558741A1/en not_active Abandoned
- 2005-04-21 EP EP05736028A patent/EP1740558A1/en not_active Withdrawn
- 2005-04-21 JP JP2007508968A patent/JP2007533718A/en not_active Withdrawn
- 2005-04-21 AU AU2005235786A patent/AU2005235786A1/en not_active Abandoned
- 2005-04-21 WO PCT/GB2005/001519 patent/WO2005103019A1/en not_active Application Discontinuation
- 2005-04-21 BR BRPI0510075-5A patent/BRPI0510075A/en not_active IP Right Cessation
-
2006
- 2006-08-29 IL IL177750A patent/IL177750A0/en unknown
- 2006-11-02 NO NO20065057A patent/NO20065057L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20065057L (en) | 2006-11-21 |
JP2007533718A (en) | 2007-11-22 |
AU2005235786A1 (en) | 2005-11-03 |
CA2558741A1 (en) | 2005-11-03 |
WO2005103019A1 (en) | 2005-11-03 |
IL177750A0 (en) | 2006-12-31 |
EP1740558A1 (en) | 2007-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE398125T1 (en) | QUINAZOLINE DERIVATIVES AS TGF BETA INHIBITORS | |
EA200970461A1 (en) | SUBSTITUTED DERIVATIVES 3-ISOBUTYL-9,10-DIMETOXI-1,3,4,6,7,11b-HEXAHYDRO-2H-PYRIDO [2,1-a] IZOHINOLIN-2-OLA AND RELATED METHODS | |
CY1110317T1 (en) | 3-Substituted-4-Pyrimidone Derivative | |
AR058077A1 (en) | DERIVATIVES OF PHENOXYACETIC ACIDS | |
AR052458A1 (en) | AMINO-IMIDAZOLONAS FOR THE INHIBITION OF BETA-SECRETASA | |
BR122017028096B8 (en) | compound, pharmaceutical composition, and use of the compound | |
AR054560A1 (en) | SPIROPIPERIDINE AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
BRPI0506817A (en) | selective kinase inhibitors | |
DE602006011752D1 (en) | PHENYLGLYCINAMIDE AND PYRIDYLGLYCINAMIDE DERIVATIVES SUITABLE AS ANTICOAGULATING AGENTS | |
AR055592A1 (en) | DERIVATIVES OF 2-AMINO-5-CYCLALKYL-HYDANTOINE AS MODULATORS AND / OR INHIBITORS OF BETA-SECRETASE (BACE) | |
AR055878A1 (en) | CYCLOPROPANOCARBOXAMIDE DERIVATIVES | |
AR056691A1 (en) | PIRROLOPIRIMIDINE DERIVATIVES AS SYK INHIBITORS | |
AR056536A1 (en) | COMPOUNDS OF 2-AMINO-5- [4- (DIFLUORMETOXI) PHENYL] -5-PHENYLIMIDAZOLONE AS INHIBITORS OF THE BETA SECRETASE (BACE) | |
ATE556058T1 (en) | 1-(2H)-ISOCHINOLOONE DERIVATIVE | |
CO6341631A2 (en) | DERIVATIVES OF 1,2,4 - OXADIAZOL AND ITS THERAPEUTIC USE | |
NO20053449L (en) | 3-substituted 4-pyrimidone derivatives | |
NO20075384L (en) | Tiadiazole-substituted coumarin derivatives and their use as leukotriene biosynthesis inhibitors. | |
ECSP099335A (en) | HETEROCYCLIC COMPOUNDS CONTAINING NITROGEN AND METHODS OF USE OF THE SAME | |
CY1114767T1 (en) | N, N-Substituted 3-Aminopyrrolidine Compounds Useful as Monoamines Reflux Inhibitors | |
NO20061317L (en) | Imidazopyridine derivatives as inducible NO synthase inhibitors | |
PE20070212A1 (en) | 1,4-DIHYDROPYRIDINE-CONDENSED HETEROCYCLES, PROCESSES TO PREPARE THE SAME, USE AND COMPOSITIONS CONTAINING THEM | |
NO20076680L (en) | Selected CGRP antagonists, methods for their preparation and their use as drugs | |
NO20080033L (en) | Quinoline derivatives as NK3 antagonists | |
EA200971062A1 (en) | DERIVATIVES OF ARYLAMIDPYRIMIDONE | |
AR042362A1 (en) | DERIVATIVES OF 3H-QUINAZOLIN-4-ONA, PROCESS OF OBTAINING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |